Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection
NCT03674125
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
HCV Infection
Interventions
BIOLOGICAL:
GLS-6150
Sponsor
GeneOne Life Science, Inc.
Collaborators
[object Object]